StonvexLoading…
StonvexStonvexStonvexCore line items from DNUT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-28 | Annual 2024 2024-12-29 | Annual 2023 2023-12-31 | Annual 2023 2023-01-01 |
|---|---|---|---|---|
Revenue | $1.52B | $1.67B | $1.69B | $1.53B |
Operating Income | $-469.27M | $-8.73M | $13.14M | $28.98M |
Net Income | $-515.77M | $3.10M | $-37.92M | $-15.62M |
EPS (Diluted) | $-3.04 | $0.02 | $-0.23 | $-0.10 |
Total Assets | $2.59B | $3.07B | $3.24B | $3.15B |
Total Liabilities | $1.92B | $1.91B | $1.98B | $1.85B |
Cash & Equivalents | $42.39M | $28.96M | $38.19M | $35.37M |
Free Cash Flow OCF − CapEx | $-64.00M | $-74.96M | $-75.88M | $28.10M |
Shares Outstanding | 171.56M | 170.06M | 168.63M | 168.14M |